AccuLine
PrivateLast Round
Seed
Jul 14, 2024
Total Funding Raised
$5.5M
Company Overview
AccuLine operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Seed round in July 2024.
AccuLine is a medical equipment manufacturing company that is developing CORA, an accurate, non-invasive, and cost-effective exam for the early detection of Coronary Artery Disease (CAD).
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AccuLine Comparables
Compare AccuLine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Powerful Medical | 71% | |
| Pulxion Medical Technology | 68% | |
| HeartSciences Inc. | 68% |
For institutional investors. Book with your work email.
AccuLine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 14, 2024 | ||||
| Pre Seed | Jul 6, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AccuLine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| eHealth Ventures | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 493% MoM to 10.4K.
- May 6, 2025
Grew 27% QoQ from 11 to 14 employees.
For institutional investors. Book with your work email.
AccuLine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AccuLine's valuation, stock price, and market status.
Is AccuLine a public or private company?
AccuLine is a private company.
What is the current stock price of AccuLine?
AccuLine is a private company, so its shares have no public market price. Caplight tracks AccuLine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AccuLine worth (valuation)?
Valuation information for AccuLine is not publicly available.
Can I buy AccuLine stock?
AccuLine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AccuLine's last funding round?
AccuLine's most recent funding round was Seed on July 14, 2024.
Who are the main investors in AccuLine?
Key investors in AccuLine include eHealth Ventures.
Will AccuLine IPO soon?
No public IPO plans have been announced for AccuLine.
How can I track AccuLine secondary market activity?
Caplight tracks bids, offers, and trades in AccuLine's shares on secondary markets.